Our Mission
Since 1993, Dendrite Clinical Systems has been helping healthcare professionals collect, record and interpret their data to improve patient outcomes. Dendrite offers specialist clinical databases, analysis software, consultancy and publishing services that empower the international healthcare sector with the intelligence they need.
Benefitting from our global user community and extensive specialist experience, our clients are able to translate the process of patient care into valuable, meaningful data through their Dendrite solution.
In this ever-changing world, healthcare systems must continually adapt and evolve to deliver effective and sustainable patient care. With a greater emphasis being placed on clinical governance and evidence-based medicine, Dendrite is the clear choice for collecting and analysing data to facilitate comprehensive reporting and improved patient outcomes to your professional practice.
Dendrite Clinical Systems is delighted to report that our Managing Director, Dr Peter Walton, has published a chapter discussing the value of clinical registries in new publication on Laparoscopic Sleeve Gastrectomy (LSG). In his Chapter, Dr Peter Walton outlines value of national bariatric registries and their capability to deliver evidence on a global basis, as well as providing some practical perspectives on best practice when setting out to start a national registry and how to keep a good registry going.
Dendrite Clinical Systems and the Institute for Health Research (IGES) in Berlin, Germany, have initiated the Outpatient Treatment of COVID-19 Infections (ABC-19) study, to record data on the treatment of COVID-19 patients and discover more about the outpatient course of the disease, the individual risk factors of patients that contribute to severe COVID-19 courses and the procedures of general practitioners (GPs).
Researchers at the University College London and University College London Hospitals NHS Foundation Trust), London, UK, have reported that the vast majority of participants with new onset loss of smell were positive for COVID19, and this acute loss of sense of smell needs to be considered globally as a criterion for self-isolation, testing and contact tracing in order to contain the spread of COVID-19.
Dendrite Clinical Systems’ innovative “Intellect Web” software has been chosen by an international group of 17 leading diabetes experts from the multidisciplinary Diabetes Surgery Summit (DSS), as the platform on which the CoviDiab project will establish a Global Registry to collect new cases of diabetes in patients with COVID-19.


